Geode Capital Management’s BioAge Labs BIOA Stock Holding History

Geode Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.53M	Sell	921,507 -82,757	-8%	-$1.15M	﹤0.01%	2703
2026 Q2	$24.6M	Buy	1,004,264 +254,998	+34%	+$4.61M	﹤0.01%	2026
2026 Q1	$13.1M	Buy	749,266 +157,889	+27%	+$3.04M	﹤0.01%	2219
2025 Q4	$7.83M	Buy	591,377 +28,646	+5%	+$254K	﹤0.01%	2528
2025 Q3	$3.31M	Buy	562,731 +109,276	+24%	+$512K	﹤0.01%	2984
2025 Q2	$1.87M	Buy	453,455 +171,426	+61%	+$691K	﹤0.01%	3167
2025 Q1	$1.06M	Buy	282,029 +25,034	+10%	+$116K	﹤0.01%	3290
2024 Q4	$1.49M	Buy	+256,995	New	+$4.43M	﹤0.01%	3233

Other funds holding BIOA

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Alessandra Capital Management Torrance, California $142M AUM 42.73% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Geode Capital Management's BIOA Position: Q3 2026 in Review

Geode Capital Management reduced its BioAge Labs (BIOA) stake by 8.2% in Q3 2026, selling an estimated $1.15M and leaving 921,507 shares worth $6.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2703.

Geode Capital Management first reported a position in BIOA in Q4 2024 and has held it in 8 quarters since. The position peaked at $24.6M in Q2 2026. 45 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

Geode Capital Management held 921,507 shares of BioAge Labs worth $6.53M as of Q3 2026.
Geode Capital Management sold 82,757 BioAge Labs shares in Q3 2026, an estimated $1.15M.
BioAge Labs made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2703 holding.
Geode Capital Management first reported a position in BioAge Labs in Q4 2024 and has held it in 8 quarters since.
Geode Capital Management's BioAge Labs position peaked at $24.6M in Q2 2026.
45 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.